市場調査レポート

商品コード

1561566

外用鎮痛剤市場レポート：治療クラス、製剤、タイプ、流通チャネル、地域別、2024年～2032年

Topical Pain Relief Market Report by Therapeutic Class, Formulation, Type (Prescription Pain Relief, Over the Counter Pain Relief), Distribution Channel, and Region 2024-2032

出版日: 2024年09月10日 | 発行: IMARC

| ページ情報: 英文 138 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel (Single User License)

USD 2,999 452,729円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,999 603,689円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 754,649円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.96円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の外用鎮痛剤市場の市場規模は2023年に105億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに171億米ドルに達し、2024年から2032年の間に5.3％の成長率（CAGR）を示すと予測しています。世界市場は主に、関節炎や筋骨格系疾患の有病率の上昇、ドラッグデリバリー技術の継続的な進歩、非侵襲的・非薬物療法に対する消費者の嗜好の高まり、研究開発への多額の投資によって牽引されています。

外用鎮痛剤市場分析：

市場の成長と規模：関節炎や筋骨格系疾患の有病率の増加、ドラッグデリバリー技術の進歩、非薬物療法への嗜好の高まりなどの要因によって、市場は力強い成長を遂げています。市場規模は相当なもので、処方薬と市販薬の両方の疼痛緩和ニーズに対応する多様な製品があり、拡大を続けています。
主な市場促進要因関節炎や筋骨格系疾患の罹患率の上昇、特に世界人口の高齢化は、疼痛緩和製品の需要を促進する主要な要因です。ドラッグデリバリーシステムの技術的進歩は、有効性の向上と放出制御を提供し、市場成長に大きく貢献しています。
技術の進歩：マイクロカプセル化やナノ製剤を含むドラッグデリバリー技術の継続的な進歩により、疼痛緩和製品の有効性と効率が向上しています。浸透性を高め、効果を長時間持続させる革新的な製剤は、効果的で便利な疼痛管理ソリューションを求める消費者の嗜好に対応しています。
産業用途：疼痛緩和製品は、関節炎、筋緊張、捻挫、スポーツ関連の怪我など、様々な症状の治療に幅広く使用されています。同市場は、重度の疼痛症状に対する処方箋に基づく治療と、自己管理可能な軽度の疼痛緩和ニーズに対する市販の選択肢の両方に対応しています。
主要市場動向：
非薬理学的・非侵襲的治療に対する消費者の嗜好の高まりが顕著な傾向となっており、疼痛緩和製品の受け入れ拡大に繋がっています。天然成分やオーガニック成分を含む製品レンジの拡大は、ホリスティックでウェルネスを重視するヘルスケアのトレンドと一致しています。
地理的動向：
北米は、慢性疼痛疾患の有病率の高さ、確立されたヘルスケア・インフラ、継続的な研究開発イニシアチブを背景に市場をリードしています。アジア太平洋地域は、人口の多さ、ヘルスケア意識の高まり、可処分所得の増加により急成長を遂げています。
競合情勢：
市場の主なプレーヤーは、革新的な製剤の導入、ドラッグデリバリーシステムの強化、製品ポートフォリオの拡充のため、研究開発に投資しています。パートナーシップ、提携、買収は、市場での地位を強化し、補完的な能力を活用するための一般的な戦略です。
課題と機会：
厳しい規制の枠組み、特に処方箋に基づく製品は、製品開拓と市場参入に課題をもたらします。絶え間ないイノベーションによる消費者の多様なニーズへの対応、オンライン流通チャネルの活用、アンメット・ヘルスケアのニーズがある新興市場の開拓などがチャンスとなります。

外用鎮痛剤市場動向：

関節炎および筋骨格系疾患の有病率の増加

クリーム、ゲル、パッチなどの局所鎮痛剤は、経口薬に比べて全身的な副作用のリスクが低く、標的を絞った鎮痛を提供します。このため、複数の健康問題や薬剤を管理している可能性のある高齢患者にとっては、特に魅力的な製品です。さらに、経口鎮痛薬に代わる有効な選択肢として局所療法に対する認識と受容が高まっていることも、市場の成長に寄与しています。変形性関節症や関節リウマチのような症状を持つ患者は、局所的な痛みを即座に緩和し、生活の質を向上させる外用薬が有効であることに気付くことが多いです。また、浸透性を高め、効果をより長く持続させる革新的な製剤の開発も、こうした製品に対する消費者の嗜好を後押ししています。

ドラッグデリバリー技術の絶え間ない進歩

ドラッグデリバリー技術の絶え間ない進歩も市場を牽引しています。マイクロカプセル化やナノ製剤などの革新的な送達システムにより、疼痛緩和製品の効能と効率が大幅に向上しています。これらの技術により、皮膚への浸透性向上、放出制御、有効医薬品成分（API）の標的への送達が可能になり、疼痛管理結果の改善につながります。非侵襲的な送達方法の開発は、従来の経口薬に比べて副作用が少なく、全身への曝露が少ない治療に対する消費者の嗜好の高まりと一致しています。ドラッグデリバリー技術の向上はまた、既存薬の再製剤化の機会を開き、性能と患者のコンプライアンスを向上させることで、旧来のAPIを活性化させる可能性もあります。

研究開発（R&D）への投資の増加

市場は、製薬企業による研究開発投資の増加によってさらに活性化されます。この投資は、既存製品の改良と、より優れた有効性、より長い作用時間、より少ない副作用を持つ新製剤の開発を目的としています。また、天然素材やオーガニック製品に対する消費者の嗜好の高まりに対応し、鎮痛作用を持つ新規有効成分や天然化合物の探索にも研究開発の重点が置かれています。こうした技術革新は製品の有効性を高め、競争の激しい市場で製品を差別化するのに役立ちます。製品ポートフォリオの拡充により、さまざまな有効成分やさまざまな強さの製品を取り揃えることで、消費者のニーズや嗜好の多様化に対応しています。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ
- 市場動向
- 市場内訳：国別
- 市場予測

第11章 SWOT分析

概要
強み
弱み
機会
脅威

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第14章価格分析

第15章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Advacare Pharma
- Exzell Pharma Inc.
- Glaxosmithkline Plc
- Johnson & Johnson
- Novartis AG
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- Sanofi S.A.
- Sun Pharmaceutical Industries Limited
- Topical Biomedics Inc.

図表

List of Figures

Figure 1: Global: Topical Pain Relief Market: Major Drivers and Challenges
Figure 2: Global: Topical Pain Relief Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Topical Pain Relief Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Topical Pain Relief Market: Breakup by Therapeutic Class (in %), 2023
Figure 5: Global: Topical Pain Relief Market: Breakup by Formulation (in %), 2023
Figure 6: Global: Topical Pain Relief Market: Breakup by Type (in %), 2023
Figure 7: Global: Topical Pain Relief Market: Breakup by Distribution Channel (in %), 2023
Figure 8: Global: Topical Pain Relief Market: Breakup by Region (in %), 2023
Figure 9: Global: Topical Pain Relief (Non-Opioids) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Topical Pain Relief (Non-Opioids) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Topical Pain Relief (Opioids) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Topical Pain Relief (Opioids) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Topical Pain Relief (Cream) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Topical Pain Relief (Cream) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Topical Pain Relief (Gel) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Topical Pain Relief (Gel) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Topical Pain Relief (Spray) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Topical Pain Relief (Spray) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Topical Pain Relief (Patch) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Topical Pain Relief (Patch) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Topical Pain Relief (Other Formulations) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Topical Pain Relief (Other Formulations) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Topical Pain Relief (Prescription Pain Relief) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Topical Pain Relief (Prescription Pain Relief) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Topical Pain Relief (Over the Counter (OTC) Pain Relief) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Topical Pain Relief (Over the Counter (OTC) Pain Relief) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Topical Pain Relief (Pharmacy and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Topical Pain Relief (Pharmacy and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Topical Pain Relief (Retail Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Topical Pain Relief (Retail Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Topical Pain Relief (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Topical Pain Relief (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: North America: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: North America: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: United States: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: United States: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Canada: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Canada: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Asia-Pacific: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Asia-Pacific: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: China: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: China: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Japan: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Japan: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: India: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: India: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: South Korea: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: South Korea: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Australia: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Australia: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Indonesia: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Indonesia: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Others: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Others: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Europe: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Europe: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Germany: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Germany: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: France: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: France: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: United Kingdom: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: United Kingdom: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Italy: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Italy: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Spain: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Spain: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Russia: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Russia: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Others: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Others: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Latin America: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Latin America: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Brazil: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Brazil: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Mexico: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Mexico: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Others: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Others: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Middle East and Africa: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Middle East and Africa: Topical Pain Relief Market: Breakup by Country (in %), 2023
Figure 81: Middle East and Africa: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Global: Topical Pain Relief Industry: SWOT Analysis
Figure 83: Global: Topical Pain Relief Industry: Value Chain Analysis
Figure 84: Global: Topical Pain Relief Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Topical Pain Relief Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Topical Pain Relief Market Forecast: Breakup by Therapeutic Class (in Million US$), 2024-2032
Table 3: Global: Topical Pain Relief Market Forecast: Breakup by Formulation (in Million US$), 2024-2032
Table 4: Global: Topical Pain Relief Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 5: Global: Topical Pain Relief Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Topical Pain Relief Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Topical Pain Relief Market: Competitive Structure
Table 8: Global: Topical Pain Relief Market: Key Players

Product Code: SR112024A4441

The global topical pain relief market size reached US$ 10.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. The global market is primarily driven by the rising prevalence of arthritis and musculoskeletal disorders, continual advancements in drug delivery technologies, increasing consumer preference for non-invasive and non-pharmacological treatments, and significant investment in research and development.

Topical Pain Relief Market Analysis:

Market Growth and Size: The market is experiencing robust growth, driven by factors such as the increasing prevalence of arthritis and musculoskeletal disorders, advancements in drug delivery technologies, and the growing preference for non-pharmacological treatments. The market size is substantial and continues to expand, with a diverse range of products catering to both prescription and over-the-counter pain relief needs.
Major Market Drivers: The rising incidence of arthritis and musculoskeletal conditions, particularly with an aging global population, is a major driver propelling the demand for pain relief products. Technological advancements in drug delivery systems, offering enhanced efficacy and controlled release, contribute significantly to market growth.
Technological Advancements: Ongoing advancements in drug delivery technologies, including microencapsulation and nano-formulations, are improving the efficacy and efficiency of pain relief products. Innovative formulations with enhanced penetration and longer-lasting effects are addressing consumer preferences for effective and convenient pain management solutions.
Industry Applications: Pain relief products find extensive applications in treating various conditions such as arthritis, muscle strains, sprains, and sports-related injuries. The market caters to both prescription-based treatments for severe pain conditions and over-the-counter options for self-manageable, milder pain relief needs.
Key Market Trends:
Growing consumer preference for non-pharmacological and non-invasive treatments is a prominent trend, leading to increased acceptance of pain relief products. The expansion of the product range to include natural and organic ingredients aligns with the trend towards holistic and wellness-focused healthcare.
Geographical Trends:
North America leads the market, driven by a high prevalence of chronic pain conditions, a well-established healthcare infrastructure, and ongoing research and development initiatives. Asia Pacific is witnessing rapid growth due to a large population, increasing healthcare awareness, and rising disposable incomes.
Competitive Landscape:
Key players in the market are investing in research and development to introduce innovative formulations, enhance drug delivery systems, and expand their product portfolios. Partnerships, collaborations, and acquisitions are common strategies to strengthen market positions and leverage complementary capabilities.
Challenges and Opportunities:
Stringent regulatory frameworks, especially for prescription-based products, pose challenges in product development and market entry. Opportunities lie in addressing the diverse needs of consumers through continuous innovation, leveraging online distribution channels, and tapping into emerging markets with unmet healthcare needs.

Topical Pain Relief Market Trends:

Increasing prevalence of arthritis and musculoskeletal disorders

Topical pain relief products, such as creams, gels, and patches, offer targeted pain relief with a lower risk of systemic side effects compared to oral medications. This makes them particularly appealing for elderly patients who may be managing multiple health issues and medications. Moreover, the increasing awareness and acceptance of topical therapies as a viable alternative to oral analgesics further contribute to the market growth. Patients with conditions, such as osteoarthritis and rheumatoid arthritis often find that topical applications provide immediate relief from localized pain, improving their quality of life. The development of innovative formulations with enhanced penetration and longer-lasting effects also drives consumer preference towards these products.

Continual advancements in drug delivery technologies

The market is also driven by continuous advancements in drug delivery technologies. Innovative delivery systems, including microencapsulation and nano-formulations have significantly enhanced the efficacy and efficiency of pain relief products. These technologies enable better skin penetration, controlled release, and targeted delivery of active pharmaceutical ingredients (APIs), leading to improved pain management outcomes. The development of non-invasive delivery methods aligns with the growing consumer preference for treatments with fewer side effects and lower systemic exposure compared to traditional oral medications. Enhanced drug delivery technologies also open up opportunities for the reformulation of existing drugs, potentially revitalizing older APIs with improved performance and patient compliance.

Increased investment in research and development (R&D)

The market is further propelled by increased investment in research and development by pharmaceutical companies. This investment is aimed at improving existing products and developing new formulations with better efficacy, longer duration of action, and fewer side effects. R&D efforts are also focused on exploring novel active ingredients and natural compounds with analgesic properties, catering to the growing consumer preference for natural and organic products. These innovations enhance product effectiveness and aid in differentiating products in a competitive market. The expansion of the product portfolio to include a range of active ingredients and varying strengths caters to diverse consumer needs and preferences.

Topical Pain Relief Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on therapeutic class, formulation, type, and distribution channel.

Breakup by Therapeutic Class:

Non-Opioids
Opioids

Non-opioids accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the therapeutic class. This includes non-opioids and opioids. According to the report, non-opioids represented the largest segment.

The non-opioids segment holds the largest share in the global market, driven by their widespread acceptance and lower risk profile compared to opioids. This segment includes products containing active ingredients such as NSAIDs capsaicin, lidocaine, and salicylates. Non-opioid topical analgesics are favored for their efficacy in treating mild to moderate pain, particularly in conditions, including arthritis, muscle strains, and sprains. Their popularity is further bolstered by the minimal risk of addiction and fewer systemic side effects, making them suitable for a broader range of patients, including the elderly and those with chronic conditions.

On the contrary, the opioids segment, although smaller compared to non-opioids, plays a crucial role in the market, particularly for patients with severe or chronic pain unresponsive to non-opioid treatments. Topical opioids typically include formulations with controlled concentrations of active substances, including morphine, fentanyl, and buprenorphine. The advantage of topical opioids lies in their ability to provide potent pain relief directly at the site of pain with reduced systemic exposure.

Breakup by Formulation:

Cream
Gel
Spray
Patch
Others

Patch holds the largest share in the industry

A detailed breakup and analysis of the market based on the formulation have also been provided in the report. This includes cream, gel, spray, patch, and others. According to the report, patch accounted for the largest market share.

The patch segment dominates the market segmentation based on formulation in the market. Patches offer a convenient and sustained-release delivery system for active pharmaceutical ingredients, ensuring prolonged and controlled pain relief. These patches are applied directly to the skin, providing localized treatment with minimal systemic absorption. The popularity of patches can be attributed to their ease of use and long-lasting effects, making them particularly appealing for patients seeking continuous pain management. The transdermal delivery method minimizes the need for frequent reapplication, enhancing patient compliance. Additionally, patches are available in various strengths, catering to a diverse range of pain intensities and conditions.

On the other hand, creams are well-received for their smooth texture and quick absorption, providing rapid relief to localized areas of pain. This formulation is favored for its ease of application and the ability to cover larger surface areas, making it suitable for conditions such as arthritis and muscle soreness. Creams often contain active ingredients, including NSAIDs, menthol, or camphor, addressing various types of pain.

Furthermore, the gel segment in the global market holds a significant share, driven by its suitability for targeted pain relief and versatility in application. Gels provide a cooling or warming sensation upon application, offering an additional layer of comfort for users. This formulation is popular for its quick absorption and ability to deliver active ingredients directly to the affected area. Gels are commonly used for conditions like arthritis, joint pain, and muscle strains.

Moreover, the spray segment is a dynamic and expanding category in the market, gaining traction for its convenient and precise application. Pain relief sprays are known for their quick and even distribution of active ingredients over the affected area, providing instant relief. This formulation is often preferred for its non-greasy nature and the ability to reach areas that may be challenging to treat with creams or patches.

Breakup by Type:

Prescription Pain Relief
Over the Counter (OTC) Pain Relief

The report has provided a detailed breakup and analysis of the market based on the type. This includes prescription pain relief and over the counter (OTC) pain relief.

Prescription pain relief formulations often contain potent active ingredients and may include opioids or higher concentrations of non-opioid analgesics. These products are typically recommended by healthcare practitioners after a thorough assessment of the patient's medical history and pain severity. The prescription segment adheres to strict regulatory controls and is subject to healthcare provider oversight to ensure appropriate use and minimize the risk of adverse effects. The demand for prescription pain relief is driven by patients with conditions such as post-surgical pain, neuropathic pain, or other complex pain syndromes that may not be effectively managed by over-the-counter alternatives.

On the contrary, over the counter (OTC) pain relief segment constitutes a substantial portion of the pain relief market, appealing to consumers seeking accessible and self-manageable solutions for mild to moderate pain. OTC products are available without the need for a prescription, allowing consumers to make independent choices for their pain management needs.

Breakup by Distribution Channel:

Pharmacy and Drug Stores
Retail Stores
Online Stores

Online stores exhibit a clear dominance in the market

A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes pharmacy and drug stores, retail stores, and online stores. According to the report, online stores accounted for the largest market share.

The online stores segment stands out as the largest in the market segmentation based on distribution channels for pain relief products. The rise of e-commerce has transformed the way consumers purchase healthcare products, including pain relief solutions. Online stores offer a vast array of choices, allowing consumers to explore different brands, formulations, and customer reviews before making a purchase decision. The convenience of doorstep delivery further enhances the appeal of online channels, particularly for individuals with mobility issues or those seeking a discreet shopping experience. The online segment benefits from the global reach, enabling consumers to access a diverse range of products that may not be available in local stores.

On the other hand, the retail stores segment is another significant distribution channel for pain relief products, encompassing a diverse range of general merchandise and convenience stores. Retail stores offer accessibility to a broad consumer base, making pain relief products readily available during routine shopping trips. These outlets typically stock a variety of over-the-counter pain relief options, appealing to consumers seeking convenience and a quick purchase experience.

Furthermore, the pharmacy and drug stores segment represent a significant portion of the market for pain relief products, offering a traditional and trusted distribution channel for consumers seeking immediate access to pain management solutions. These establishments provide a wide range of over the counter and prescription pain relief products, allowing customers to receive personalized recommendations from pharmacists.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America leads the market, accounting for the largest topical pain relief market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America stands out as the largest segment for pain relief products. The region's dominance is attributed to several factors, including a high prevalence of chronic pain conditions, a well-established healthcare infrastructure, and a strong emphasis on research and development. North America has a substantial aging population, contributing to an increased incidence of musculoskeletal disorders and arthritis, augmenting the demand for effective pain relief solutions. Additionally, the region's proactive approach to healthcare, coupled with a higher awareness of pain management options, supports the robust growth of the topical pain relief market.

On the other hand, the Asia Pacific region is a dynamic and rapidly growing segment in the market for pain relief products. Factors such as a large population, increasing healthcare awareness, and rising disposable incomes contribute to the expanding market in this region. As lifestyles become more sedentary and the aging population grows, there is a rise in the prevalence of chronic conditions, fueling the demand for effective pain management solutions. Moreover, the cultural acceptance of topical therapies, along with the availability of a diverse range of traditional remedies, adds to the market's versatility.

Additionally, Europe represents a significant market segment for pain relief products, characterized by a mature healthcare system, a high prevalence of chronic conditions, and a strong emphasis on wellness. The region's aging population contributes to the demand for pain management solutions, particularly for conditions, including osteoarthritis and rheumatoid arthritis. European consumers are increasingly inclined towards non-pharmacological and non-invasive pain relief options, aligning with the global trend.

Moreover, Latin America emerges as a significant and growing market segment for pain relief products, driven by factors such as a rising middle class, increasing healthcare awareness, and a growing aging population. The region experiences a considerable burden of musculoskeletal disorders and sports-related injuries, propelling the demand for effective pain relief solutions.

Furthermore, the Middle East and Africa represent a developing market segment for pain relief products. The region's market is influenced by factors such as a growing population, improving healthcare infrastructure, and an increasing awareness of pain management options. Chronic conditions, including musculoskeletal disorders, are on the rise, contributing to the demand for pain relief solutions.

Leading Key Players in the Topical Pain Relief Industry:

Key players in the market are actively engaged in strategic initiatives to maintain and expand their market presence. This includes investments in research and development to introduce innovative formulations, enhanced drug delivery systems, and novel active ingredients. Companies are focusing on expanding their product portfolios to address a wide range of pain conditions and consumer preferences. Additionally, marketing efforts emphasize the efficacy and safety of their products, targeting both healthcare professionals and informed consumers. Partnerships, collaborations, and acquisitions are common strategies to strengthen market positions and leverage complementary capabilities.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Advacare Pharma
Exzell Pharma Inc.
Glaxosmithkline Plc
Johnson & Johnson
Novartis AG
Pfizer Inc.
Reckitt Benckiser Group Plc
Sanofi S.A.
Sun Pharmaceutical Industries Limited
Topical Biomedics Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

31 August 2023: Johnson & Johnson launched new pain solution, the topical Tylenol(R) Precise(TM) Pain Relieving Cream. Tylenol Precise fits active lifestyles with a rapid-absorbing formula, fragrance-free and fresh scent options for discreet use, and a uniquely designed rollerball for hands-free, no-mess application leaving skin clear of sticky residues.
23 June 2023: Exzell Pharma Inc., the brand house of Myoflex, announced a multiyear partnership with Pickleball Canada, the National Sport Organization for pickleball. Myoflex has been used by active people of all ages and abilities for muscle aches, strains, and pains.
24 February 2021: Reckitt Benckiser Group Plc announced that it has entered into a definitive agreement to acquire the Biofreeze brand from Performance Health. The acquisition represents a unique and exciting opportunity to unlock value through RB's expertise, global operating footprint, and infrastructure. Biofreeze is a perfect fit with RB's Health platform and deepens RB's presence within the broader pain category.

Key Questions Answered in This Report:

How has the global topical pain relief market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global topical pain relief market?
What is the impact of each driver, restraint, and opportunity on the global topical pain relief market?
What are the key regional markets?
Which countries represent the most attractive topical pain relief market?
What is the breakup of the market based on the therapeutic class?
Which is the most attractive therapeutic class in the topical pain relief market?
What is the breakup of the market based on the formulation?
Which is the most attractive formulation in the topical pain relief market?
What is the breakup of the market based on the type?
Which is the most attractive type in the topical pain relief market?
What is the breakup of the market based on the distribution channel?
Which is the most attractive distribution channel in the topical pain relief market?
What is the competitive structure of the market?
Who are the key players/companies in the global topical pain relief market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Topical Pain Relief Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Therapeutic Class

6.1 Non-Opioids
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Opioids
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Formulation

7.1 Cream
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Gel
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Spray
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Patch
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Type

8.1 Prescription Pain Relief
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Over the Counter (OTC) Pain Relief
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Pharmacy and Drug Stores
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Retail Stores
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Online Stores
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Advacare Pharma
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 Exzell Pharma Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Glaxosmithkline Plc
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Johnson & Johnson
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
- 15.3.5 Novartis AG
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Pfizer Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Reckitt Benckiser Group Plc
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Sanofi S.A.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Sun Pharmaceutical Industries Limited
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Topical Biomedics Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio

外用鎮痛剤市場レポート：治療クラス、製剤、タイプ、流通チャネル、地域別、2024年～2032年

Topical Pain Relief Market Report by Therapeutic Class, Formulation, Type (Prescription Pain Relief, Over the Counter Pain Relief), Distribution Channel, and Region 2024-2032

外用鎮痛剤市場分析：

外用鎮痛剤市場動向：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の外用鎮痛剤市場

第6章 市場内訳：治療クラス別

第7章 市場内訳：剤形別

第8章 市場内訳：タイプ別

第9章 市場内訳：流通チャネル別

第10章 市場内訳：地域別

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢